PharmaLundensis main project is to develop a new, effective treatment for the severe lung disease chronic obstructive pulmonary diseas, COPD, based on a new mechanism of action. We know of several patients with severe COPD who, after taking iodinated activated charcoal (Iodocarb) for some time, have experienced a dramatic improvement of the lung function. One person was virtually healed from his disease. Iodinated activated charcoal binds heavy metals and removes them from the body. COPD is often caused by tobacco smoking which contains considerable amounts of heavy metals such as lead, cadmium and mercury.
Treating COPD by removing heavy metals from the body is a new concept. No present treatment work like this. As a matter of fact, todays treatment only give some short-term relief, while Iodocarb has the potential to CURE the disease.
After successful clinical trials Iodocarb has the potential to be a blockbuster drug with annual sales exceering 1 billion USD.